drugset
drugset / Trial / NCT01037881

LEO 29102 Cream in the Treatment of Atopic Dermatitis

NCT01037881 ↗

Phase 2 Completed 183 enrolled LEO Pharma
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a proof of concept and dose finding Phase II trial comparing 5 dose strengths with vehicle and an active comparator (Elidel cream 10 mg/g) in a 4 week, twice daily treatment regimen in mild to moderate atopic dermatitis patients.

Timeline

Start
2009-12
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject LEO 29102 Unknown 0.03 unknown Topical
Subject LEO 29102 Unknown 0.1 unknown Topical
Subject LEO 29102 Unknown 0.3 unknown Topical
Subject LEO 29102 Unknown 1 unknown Topical
Subject LEO 29102 Unknown 2.5 unknown Topical
Comparator Pimecrolimus Small molecule 10 unknown Topical

Indications

atopic eczema